Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06745167
- Locations
- 🇨🇳
No. 241, West Huaihai Road, Shanghai, Shanghai, China
Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 418
- Registration Number
- NCT06742866
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Xuhui, China
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 304
- Registration Number
- NCT06740539
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06739512
- Locations
- 🇨🇳
No. 241, West Huaihai Road, Shanghai, Shanghai, China
Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06730503
- Locations
- 🇨🇳
Xiaomin Niu, Shanghai, Shanghai, China
Sd-RAB for the Diagnosis of PPLs
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06719687
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT06709417
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT06698965
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06690671
- Locations
- 🇨🇳
241, West Huaihai Road, Shanghai, Shanghai, Shanghai 200030, Shanghai, Shanghai, China
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06688656
- Locations
- 🇨🇳
241, West Huaihai Road, Shanghai, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath